AK
Amit Kumar
About Amit Kumar
Data last updated:
Amit Kumar is a Director at Younker Pharmaceutical Private Limited (since 2017) and Director at Shorya Pranjal Infratech Private Limited (since 2017). The companies operate in Pharma and Construction. The 2 current companies with reported revenue have a combined latest revenue of ₹60.6 Lakh; the largest is Younker Pharmaceutical Private Limited at ₹47.7 Lakh (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 21 Jul 2017 | 2017 | ₹47.7 Lakh (FY 2023) | Active | |
| Director | 10 Apr 2017 | 2017 | ₹12.9 Lakh (FY 2025) | Active |
Board colleagues of Amit Kumar
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amit Ranjan | 07887183 | Younker Pharmaceutical Private Limited | Director |
| Saket Kumar | 07875710 | Younker Pharmaceutical Private Limited | Director |
| Virochan Kumar | 07887184 | Younker Pharmaceutical Private Limited | Director |
| Riddhi Kumari | 10455904 | Shorya Pranjal Infratech Private Limited | Director |
| Sudhanshu Shekhar | 07789490 | Shorya Pranjal Infratech Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Amit Kumar
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Amit Kumar
Amit Kumar currently holds 2 directorships: Younker Pharmaceutical Private Limited (Director, since 21 Jul 2017, revenue ₹47.7 Lakh (FY 2023)); Shorya Pranjal Infratech Private Limited (Director, since 10 Apr 2017, revenue ₹12.9 Lakh (FY 2025)).
Amit Kumar was first appointed on 10 Apr 2017 as Director at Shorya Pranjal Infratech Private Limited.
The 2 current companies of Amit Kumar that report revenue have a combined latest revenue of ₹60.6 Lakh: Younker Pharmaceutical Private Limited ₹47.7 Lakh (FY 2023); Shorya Pranjal Infratech Private Limited ₹12.9 Lakh (FY 2025).
The current boards of Amit Kumar's companies include Amit Ranjan (Younker Pharmaceutical Private Limited), Saket Kumar (Younker Pharmaceutical Private Limited), Virochan Kumar (Younker Pharmaceutical Private Limited), Riddhi Kumari (Shorya Pranjal Infratech Private Limited), Sudhanshu Shekhar (Shorya Pranjal Infratech Private Limited).